Pfizer Stomach-Cancer Drug Passes Test (Reuters)


Reuters - Pfizer Inc. said on Tuesday
its experimental drug for a deadly form of stomach cancer
proved safe and effective in a late-stage trial, prompting
researchers to halt the study seven months ahead of schedule.

Read more...